Lyell Immunopharma
LYEL
LYEL
113 hedge funds and large institutions have $81.8M invested in Lyell Immunopharma in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 7 closing their positions.
Holders
113
Holders Change
+8
Holders Change %
+7.62%
% of All Funds
1.54%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
16
Increased
23
Reduced
36
Closed
7
Calls
$2K
Puts
$3K
Net Calls
-$1K
Net Calls Change
-$2K
Top Buyers
Top Sellers
1 |
O
1
OrbiMed
New York
|
$0 |
2 |
2
Millennium Management
New York
|
$23.1K |
3 |
3
D.E. Shaw & Co
New York
|
$41.5K |
4 |
![]()
4
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$301K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$59.4K |